The immune system contributes to the effectiveness of vaccine therapy in patients with metastatic melanoma
The aim of the study was to identify differences in the immune system parameters between metastatic melanoma patients who responded and did not respond to dendritic cell vaccination.Material and Methods. The study group included 20 patients with stage III–IV metastatic melanoma, who received vaccine...
Saved in:
| Main Authors: | I. N. Mikhaylova, M. N. Stakheyeva, I. Zh. Shubina, G. Z. Chkadua, A. A. Borunova, R. A. Zukov, I. V. Bogdashin, E. L. Choynzonov, N. V. Cherdyntseva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2023-05-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/2528 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
by: Yu. A. Khochenkova, et al.
Published: (2014-07-01) -
Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma
by: Robert O Dillman, et al.
Published: (2019-06-01) -
Phenotypic plasticity of metastatic melanoma
by: I. N. Mikhaylova, et al.
Published: (2019-02-01) -
Systemic therapy of skin metastatic melanoma with BRAF gene mutation
by: Yu. S. Shakh-Paronyants, et al.
Published: (2023-03-01) -
ANALYSIS OF CANCER-TESTIS ANTIGENS AS POTENTIAL MARKERS FOR DISSEMINATION OF PRIMARY HUMAN SKIN MELANOMA
by: I. N. Mikhaylova, et al.
Published: (2021-06-01)